Insider Transactions in Q1 2026 at Clover Health Investments, Corp. (CLOV)
Insider Transaction List (Q1 2026)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 07
2026
|
Jamie L. Reynoso CEO, Medicare Advantage |
SELL
Open market or private sale
|
Direct |
2,102
-0.08%
|
$4,204
$2.53 P/Share
|
|
Jan 06
2026
|
Demetrios L. Kouzoukas Director |
BUY
Grant, award, or other acquisition
|
Direct |
79,365
+11.58%
|
-
|
|
Jan 06
2026
|
Carladenise Armbrister Edwards Director |
BUY
Grant, award, or other acquisition
|
Direct |
79,365
+18.37%
|
-
|
|
Jan 06
2026
|
William G Robinson Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
79,365
+11.72%
|
-
|
|
Jan 06
2026
|
Anna U Loengard Director |
BUY
Grant, award, or other acquisition
|
Direct |
79,365
+13.08%
|
-
|
|
Jan 06
2026
|
Thomas L Tran Director |
BUY
Grant, award, or other acquisition
|
Direct |
79,365
+30.6%
|
-
|
|
Jan 03
2026
|
Jamie L. Reynoso CEO, Medicare Advantage |
SELL
Payment of exercise price or tax liability
|
Direct |
8,109
-0.29%
|
$16,218
$2.41 P/Share
|
|
Jan 01
2026
|
Andrew Toy Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
267,958
-2.72%
|
$535,916
$2.35 P/Share
|